What is NEO's gross margin?

NeoGenomics (NEO) has a gross margin of 43% and a net margin of -9%.

What is NEO's P/E ratio?

Track NeoGenomics (NEO) P/E ratio, ROE, and valuation metrics over time.

Where can I see NEO's full financials?

See NeoGenomics (NEO) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

NeoGenomics (NEO) Financials — Revenue, Earnings, Cash Flow

$9.23

+0.12 (+1.32%)

Weekly Expected Move ±7.0%

$7 $8 $8 $9 $9

NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 61 · $240.4M mcap · 24M float · 8.32% daily turnover · Short 59% of daily vol

📊 Key Metrics

TTM

$746M

Revenue

+10.9% YoY

$-99M

Net Income

-27.9% YoY

$-5M

Free Cash Flow

+84.3% YoY

43.3%

Gross Margin

-9.8%

Op. Margin

-9.2%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-11.4%

ROA-6.6%

ROIC-7.2%

Valuation

P/E-2.4

P/B0.3

EV/EBITDA-15.3

Leverage

Debt/Equity0.56

Current Ratio4.26

Interest Cov.-36.4x

Quality Scores

Piotroski F4/9

Altman Z0.33

Beneish M-2.83